Cyclooxygenase-1 haplotype modulates platelet response to aspirin

This publication has 13 references indexed in Scilit:

• Aspirin and coronary artery disease
  Thrombosis and Haemostasis, 2004
• A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease
  Journal of the American College of Cardiology, 2003
• Genetic variation in cyclooxygenase 1: Effects on response to aspirin
  Clinical Pharmacology & Therapeutics, 2003
• Cyclooxygenase 1(COX1) polymorphisms in African-American and caucasian populations
  Human Mutation, 2002
• Score Tests for Association between Traits and Haplotypes when Linkage Phase Is Ambiguous
  American Journal of Human Genetics, 2002
• Genetic and Environmental Contributions to Platelet Aggregation
  Circulation, 2001
• Prior aspirin use predicts worse outcomes in patients with non–ST-elevation acute coronary syndromes
  The American Journal of Cardiology, 1999
• The structural basis of aspirin activity inferred from the crystal structure of inactivated prostaglandin H2 synthase
  Nature Structural & Molecular Biology, 1995
• Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients
  BMJ, 1994
• Selective Cumulative Inhibition of Platelet Thromboxane Production by Low-dose Aspirin in Healthy Subjects
  Journal of Clinical Investigation, 1982